BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22582593)

  • 1. [Progress in prolactin receptor research].
    Tan DY; Peng XP
    Sheng Li Ke Xue Jin Zhan; 2012 Feb; 43(1):17-23. PubMed ID: 22582593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice.
    Bole-Feysot C; Goffin V; Edery M; Binart N; Kelly PA
    Endocr Rev; 1998 Jun; 19(3):225-68. PubMed ID: 9626554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-independent dimerization of the human prolactin receptor isoforms: functional implications.
    Gadd SL; Clevenger CV
    Mol Endocrinol; 2006 Nov; 20(11):2734-46. PubMed ID: 16840534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin and the prolactin receptor: new targets of an old hormone.
    Harris J; Stanford PM; Oakes SR; Ormandy CJ
    Ann Med; 2004; 36(6):414-25. PubMed ID: 15513293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine actions of prolactin contribute to the regulation of lactotroph function in vivo.
    Bernard V; Lamothe S; Beau I; Guillou A; Martin A; Le Tissier P; Grattan D; Young J; Binart N
    FASEB J; 2018 Sep; 32(9):4791-4797. PubMed ID: 29596024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasiveness.
    Kavarthapu R; Dufau ML
    Front Endocrinol (Lausanne); 2022; 13():949396. PubMed ID: 36187116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The short form of the prolactin (PRL) receptor silences PRL induction of the beta-casein gene promoter.
    Berlanga JJ; Garcia-Ruiz JP; Perrot-Applanat M; Kelly PA; Edery M
    Mol Endocrinol; 1997 Sep; 11(10):1449-57. PubMed ID: 9280060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From the molecular biology of prolactin and its receptor to the lessons learned from knockout mice models.
    Goffin V; Binart N; Clément-Lacroix P; Bouchard B; Bole-Feysot C; Edery M; Lucas BK; Touraine P; Pezet A; Maaskant R; Pichard C; Helloco C; Baran N; Favre H; Bernichtein S; Allamando A; Ormandy C; Kelly PA
    Genet Anal; 1999 Nov; 15(3-5):189-201. PubMed ID: 10596761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in prolactin receptor (PRLR) in mouse and human fallopian tubes: evidence for multiple regulatory mechanisms controlling PRLR isoform expression in mice.
    Shao R; Nutu M; Weijdegård B; Egecioglu E; Fernandez-Rodriguez J; Tallet E; Goffin V; Ling C; Billig H
    Biol Reprod; 2008 Oct; 79(4):748-57. PubMed ID: 18596217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells.
    Scotti ML; Langenheim JF; Tomblyn S; Springs AE; Chen WY
    Breast Cancer Res Treat; 2008 Sep; 111(2):241-50. PubMed ID: 17955362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New mechanisms for PRLr action in breast cancer.
    Clevenger CV; Gadd SL; Zheng J
    Trends Endocrinol Metab; 2009 Jul; 20(5):223-9. PubMed ID: 19535262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin receptor antagonists.
    Walker AM
    Curr Opin Investig Drugs; 2005 Apr; 6(4):378-85. PubMed ID: 15898345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I.
    Fleenor D; Arumugam R; Freemark M
    Horm Res; 2006; 66(3):101-10. PubMed ID: 16735796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin signaling influences the timing mechanism of the hair follicle: analysis of hair growth cycles in prolactin receptor knockout mice.
    Craven AJ; Ormandy CJ; Robertson FG; Wilkins RJ; Kelly PA; Nixon AJ; Pearson AJ
    Endocrinology; 2001 Jun; 142(6):2533-9. PubMed ID: 11356702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin as an autocrine/paracrine factor in breast tissue.
    Clevenger CV; Plank TL
    J Mammary Gland Biol Neoplasia; 1997 Jan; 2(1):59-68. PubMed ID: 10887520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin receptor antagonists.
    Kuo CB; Coss D; Walker AM
    Endocrine; 1998 Oct; 9(2):121-31. PubMed ID: 9867245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The many faces of prolactin in breast cancer.
    Chen WY
    Adv Exp Med Biol; 2015; 846():61-81. PubMed ID: 25472534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin increases survival and migration of ovarian cancer cells: importance of prolactin receptor type and therapeutic potential of S179D and G129R receptor antagonists.
    Tan D; Chen KE; Khoo T; Walker AM
    Cancer Lett; 2011 Nov; 310(1):101-8. PubMed ID: 21775057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Prolactin Receptor mRNA in Lactotrophs and Somatotrophs of the Chicken Anterior Pituitary Gland.
    Kaneda H; Nakao N; Tsushima N; Tanaka M
    J Poult Sci; 2018; 55(2):150-154. PubMed ID: 32055168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triennial Lactation Symposium: Prolactin: The multifaceted potentiator of mammary growth and function.
    Trott JF; Schennink A; Petrie WK; Manjarin R; VanKlompenberg MK; Hovey RC
    J Anim Sci; 2012 May; 90(5):1674-86. PubMed ID: 22205663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.